{
    "nctId": "NCT02440620",
    "briefTitle": "Cardiac Toxicity in Medical Treatment of Breast Cancer",
    "officialTitle": "Cardiac Toxicity in Medical Treatment of Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Heart Failure, Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 45,
    "primaryOutcomeMeasure": "Global longitudinal strain by two dimentional speckle tracking.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of HER2 positive breast cancer\n* Adjuvant treatment with trastuzumab\n\nExclusion Criteria:\n\n* Left ventricle ejection fraction (LVEF) \\<50%\n* Chronic or persistent atrial fibrillation\n* History of moderate or severe valvular heart disease.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}